Financial Summary for the Six Months Ended March 2027 (Q2) [Japanese GAAP] (Consolidated)

Business Performance Overview

Under the GP2026 medium-term plan, the Group advanced its initiatives and achieved consolidated results for the six months ended March 2027 of revenue 28,964,707 thousand yen, operating income 2,297,501 thousand yen, ordinary income 2,445,518 thousand yen, and net income attributable to owners of parent 1,596,995 thousand yen, recording year-over-year increases in both revenue and profit. Sales and profits across nine industry-based reporting segments, including the newly established "Food, Pharmaceuticals & Cosmetics" segment, progressed steadily. Expansion in AI-related demand and needs for higher-performance machine tools drove overall performance. Furthermore, the outlook for the second half was revised upward and the year-end dividend forecast was increased.

Segment Results and Financial Position

Key segments such as steel, automotive, electronics and semiconductors boosted sales and profits, and the establishment of the Food, Pharmaceuticals & Cosmetics segment changed the business composition. Total assets were approximately 47,291 million yen and net assets approximately 30,483 million yen, with a shareholders' equity ratio maintained above 60%. A decline in accounts receivable contributed to a reduction in current assets, while cash and deposits increased slightly.